2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...
AGCO and Hexagon Agree to Expand Distribution of Hexagon¡¯s ... (2023-04-25)
KG ¸ðºô¸®Æ¼, 4¿ù 9751´ë ÆÇ¸Å¡¦ ¼öÃâ 40.1% Áõ°¡ (2024-05-03)
Cognite Launches ¡°Cognite Embedded¡± to Accelerate Innovati... (2024-10-20)
Çö´ëÂ÷, ¾ÆÀÌ¿À´Ð 5 N ¿ÃÇØÀÇ Â÷ ¼ö»ó ±â³ä °í°´ °¨»ç À̺¥Æ® (2024-03-09)
¡®¾Æºü´Â ²ÉÁ߳⡯ ±è¿øÁØ, ¾Æ¹öÁö ÇâÇÑ Â£Àº ±×¸®¿ò °í¹é (2024-05-16)
³²±ØÀ¸·Î °£ ¼¼ÀÏÁî¸Ç Á¾½Åº¸Çè ¾ÆÀ̽º¿À¼Ç ¹ß°ß (2016-12-08)
Çö¹Ìº¸´Ù ¸ö¿¡ ÁÁÀº °Ç°­½Äǰ ¡®¹Ì°­¡¯ (2015-07-01)
Canva Unveils Global Developers Platform, $50M Fund & New In... (2023-06-16)
¡®¿ì¸® ¾ÆÀÌ KB½ºÅ¸¹ðÅ· ½ÃÀÛÇϱ⡯ ¼­ºñ½º ¿ÀÇ (2023-09-26)
Jefferies Agrees Sale of OpNet Operations to Wind Tre, Subst... (2024-02-09)
ÀΰøÁö´É ÇÇÆ®´Ï½º Ç÷§Æû ¡®ÇÏÀÌ·¢½º ¿©ÀǵµÁ¡¡¯ ¿ÀÇ (2024-02-09)
Despite Increasing Cybersecurity Attacks, People Still Belie... (2024-10-12)
Introducing SafeAuth: The Powerhouse Collaboration between W... (2023-12-16)
STX¿£Áø, ģȯ°æ ¼±¹Ú¿ë ¿£Áø ½Ãµ¿½Ä (2023-09-18)
´ë¿õÁ¦¾à ¿ì·ç»çÀÇ °£ ±â´É °³¼± È¿°ú¡¦ ÀÓ»ó 4»ó¼­µµ ÀÔÁõ (2024-07-15)
LGÈ­ÇÐ, Â÷¼¼´ë ¸é¿ª°ü¹®¾ïÁ¦Á¦ °³¹ß (2024-06-24)
Neuraptive Therapeutics Receives FDA Breakthrough Therapy De... (2024-09-21)
LambdaTest launches mobile application performance analytics (2023-04-19)
ºÎ»êµµ½Ãöµµ 1È£¼± ¿¬Àå ´Ù´ë±¸°£ °³Åë½Ä (2017-04-21)
ºê·£µå¿¢½ºÄÚÆÛ·¹ÀÌ¼Ç Á§½Ã¹Í½º, ¿ÀÇÁ¶óÀÎ È®Àå °¡¼ÓÈ­ (2024-02-14)
ÄíÄÜ, ºñ´ë¸é °í°´ ÀÎÁõ ÇÁ·Î¼¼½º ±¸Çö À§ÇÑ API Á¦°ø (2024-05-13)
À¥Äɽñ۷ιú-¿µ¸²¿ø¼ÒÇÁÆ®·¦, º£Æ®³² Àü·«Àû »ç¾÷ °øµ¿ ÃßÁø (2024-06-16)
â¾÷°ú Áß¼Ò±â¾÷À» À§ÇÑ Á¤ºÎÁö¿ø »ç¾÷ °èȹ¼­ ÀÛ¼º¹ý (2017-04-10)
New Research Finds 83% of Supply Chains Can¡¯t Respond to Di... (2024-04-22)
±è´ëÈñ ¡°2¼¼ °áÈ¥½Ä ÃàÀDZݵµ µ¶¹ÚÇÏÀÚ¡± °¡Á· °æÁ¶»çµµ ¡®µ¶¹Ú... (2024-07-20)
       [ÀÌÀü][1]....[719][720][721][722][723][724][725][726][727]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..